Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin for microalbuminuria in adults with type 2 diabetes and diabetic nephropathy
IRCT20171030037093N11Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis comparing Linagliptin with Placebo (2 arms). Primary endpoints: Blood pressure and Urine albumin-to-creatinine ratio. Started May 2019; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on IRCT20171030037093N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N11.